Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans.
Murphy
D L
DL
Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland.
Lesch
K P
KP
Aulakh
C S
CS
Pigott
T A
TA
D000818:Animals; D001372:Aza Compounds / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects*; D001831:Body Temperature / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D003704:Dementia / Q000188:drug therapy; D006801:Humans; D009497:Neurotic Disorders / Q000188:drug therapy; D010879:Piperazines / Q000494:pharmacology* / Q000627:therapeutic use; D011985:Receptors, Serotonin / Q000187:drug effects*; D013134:Spiperone / Q000031:analogs & derivatives / Q000494:pharmacology
D001372:Aza Compounds; D010879:Piperazines; D011985:Receptors, Serotonin; D013134:Spiperone; C015068:1-(3-chlorophenyl)piperazine